Jeffrey Lee, MD, stepped into the role of chief medical executive Houston-based University of Texas MD Anderson Cancer Center ...

The University of Texas MD Anderson Cancer Center has commenced construction on a new 470,000ft² facility in Sugar Land, ...

The University of Texas at Austin and MD Anderson Cancer Center plan to build two new hospital towers in the downtown ...

SUGAR LAND, Texas ― The University of Texas MD Anderson Cancer Center today broke ground on a new 470,000-square-foot ...

Texas Children's Hospital and The University of Texas MD Anderson Cancer Center have announced a collaboration dedicated to ...

Houston-based University of Texas MD Anderson Cancer Center broke ground on a new facility in Sugar Land, Texas, set to be ...

The University of Texas MD Anderson Cancer in Houston has broken ground on a new 470,000-square-foot facility in Sugar Land. According to a March 31 news release, the five-story, 470,000-square-foot ...

A phase 1/2 trial of CRISPR-engineered eTIL therapy KSQ-004EX for advanced solid tumors has dosed its first patient.

Oncologists share how to prioritize yourself while undergoing the difficult treatment, and real women share how positive ...

CERo Therapeutics (CERO) announces its first clinical trial site for the Company’s Phase 1 clinical trial of CER-1236. The trial is focused on ...

CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ ...